Cancer Risk Awareness and Concern among Women with a Family History of Breast or Ovarian Cancer
- 3 November 2014
- journal article
- research article
- Published by Taylor & Francis in Behavioral Medicine
- Vol. 42 (1) , 18-28
Abstract
Women with a documented deleterious mutation in BRCA1 or BRCA2 are at substantially elevated risk for ovarian cancer. To understand what percentage of women with high-risk family histories know their risk is elevated we surveyed 1,885 women with a high- or moderate-risk family history and no personal history of breast or ovarian cancer, and asked about their perceived risk of breast and ovarian cancer. Among high-risk women, fewer than 20% reported use of genetic counseling, and knowledge of elevated risk of ovarian cancer was low. Prior genetic counseling was associated with greater perceived risk for ovarian cancer. Results suggest that most high-risk women (>75%) do not know their risk for ovarian cancer. Identification of potentially high-risk women for referral to genetic counseling may improve informed ovarian cancer risk management.Keywords
This publication has 29 references indexed in Scilit:
- SGO White Paper on Ovarian Cancer: Etiology, Screening and SurveillanceGynecologic Oncology, 2010
- Prophylactic and Risk-Reducing Bilateral Salpingo-oophorectomyObstetrics & Gynecology, 2010
- Changes in cancer worry associated with participation in ovarian cancer screeningPsycho-Oncology, 2007
- Screening for Familial Ovarian Cancer: Failure of Current Protocols to Detect Ovarian Cancer at an Early Stage According to the International Federation of Gynecology and Obstetrics SystemJournal of Clinical Oncology, 2005
- Breast cancer risk counseling improves women’s functioningPatient Education and Counseling, 2004
- Prophylactic Oophorectomy in Carriers ofBRCA1orBRCA2MutationsNew England Journal of Medicine, 2002
- Worry about Ovarian Cancer Risk and Use of Ovarian Cancer Screening by Women at Risk for Ovarian CancerGynecologic Oncology, 2002
- Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium1997
- Hypolipidemic and antioxidant effects of commiphora mukul as an adjunct to dietary therapy in patients with hypercholesterolemiaCardiovascular Drugs and Therapy, 1994
- The accuracy of patient reports of a family history of cancerJournal of Chronic Diseases, 1985